Dynavax Technologies Corporation news

   Watch this stock
Showing stories 11 - 20 of about 87   

Articles published

DVAX 29.76 +1.31 (4.60%)
price chart
Wall Street Analysts Have $39 Price Target on Dynavax Technologies Corporation ...
There are 2 research firms in total that have issued ratings on Dynavax Technologies Corporation (NASDAQ:DVAX) within the past year.
Zacks Rating on Dynavax Technologies Corporation  American Trade Journal
Can Dynavax Technologies Corporation (NASDAQ:DVAX) Keep Up with Analyst ...
Dynavax Technologies Corporation (NASDAQ:DVAX) reported an earnings surprise of 21.57% when the company last reported earnings for the period ending on 2015-06-30.
Zacks Short Term Rating on Dynavax Technologies Corporation (NASDAQ:DVAX)
As many as 3 brokerage firms have rated Dynavax Technologies Corporation (NASDAQ:DVAX) at 1. Research Analysts at Zacks have ranked the company at 2, suggesting the traders with a rating of buy for the short term.
Dynavax Technologies Corp (DVAX) Drops 8.04% on August 24  Equities.com
Early Week Pre-Market Insights: NTN Buzztime Inc. (NTN), Parker-Hannifin ...  WallStreet Scope
Will Dynavax Technologies Corporation Bounce Back in 2014?
The company has lost nearly 30% of its market value since the beginning of the year, following two major setbacks for its lead drug candidate, the adult hepatitis B vaccine Heplisav.
Related articles »  
Company Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) Rally 8.35%
Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) rose by 8.35% in the past week and 1.84% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 7.63% and the outperformance increases to 3.55% for the last 4 ...
Dynavax Technologies Corporation Analyst Rating Update  OTC Outlook
Short Interest in Dynavax Technologies Drops By 29.3% (DVAX)  Dakota Financial News
Company Update (NASDAQ:DVAX): Dynavax Technologies Corporation Reports Second ...
The Company had $93.4 million in cash, cash equivalents and marketable securities as of June 30, 2015, compared to $97.6 million at March 31, 2015.
Dynavax Technologies Corporation (NASDAQ:DVAX) Given a $39 Price Target ...  Markets Daily
Analyst Rating Update on Dynavax Technologies Corporation  OTC Outlook
Company Update (NASDAQ:DVAX): Dynavax Technologies Corporation Announces ...
Dynavax Technologies Corporation (NASDAQ:DVAX) announced the completion of an underwritten public offering of 5,227,273 shares of its common stock, including 681,818 shares sold pursuant to the full exercise of an over-allotment option previously ...
Dynavax Technologies Is A Bargain Now
Dynavax Technologies Corporation (NASDAQ:DVAX), with its HEPLISAV-B vaccine, could turn out to be a major competitor to GSK and MRK in the future.
Stock Update (NASDAQ:DVAX): Dynavax Technologies Corporation Reports First ...  Smarter Analyst
Dynavax Technologies Corporation (DVAX:NASDAQ) Analyst Price Target Update
Dynavax Technologies Corporation (DVAX:NASDAQ): The stock price is expected to reach $ 39 in the short term. The number of analysts agreeing with this consensus is 2. The higher estimate for the short term price target is at $42 while the lower ...
Company Shares of Dynavax Technologies Corporation Rally 5.49%  American Trade Journal
Dynavax Technologies Corporation (NASDAQ:DVAX) Expected to Report $-0.78
Wall Street sell-side analysts are expecting Dynavax Technologies Corporation (NASDAQ:DVAX) to report earnings of $-0.78 for the current fiscal quarter.